- Global Pharma News & Resources

Biophotonics Market to Reach US$ 95.0 Billion by 2027, Owing to Increasing Adoption of Light-based Technologies in the Agriculture Sector

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Request Sample

According to Global Biophotonics Market Report, By End Use (Medical Diagnostics, Medical Therapeutics, Test Components, and Non-Medical Applications), By Application (See Through Imaging, Inside Imaging, Spectro Molecular, Surface Imaging, Microscopy, Light Therapy, Biosensors, an Other Analytic Sensing), and By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa), published by Coherent Market Insights, the global biophotonics market was valued at US$ 49.0 billion in 2018 and is expected to witness a CAGR of 8.3% during the forecast period (2019 to 2027).

Biophotonics involves the use of light-based technologies in the life sciences, medicine, agriculture, and environmental science sectors. The emerging field uses optical techniques to image and assess biological molecules, tissues, and cells.

*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.

Request PDF Research Report Brochure @

R&D of low-cost sensors and vectors for plant phenotyping is expected to propel growth of the global biophotonics market. For instance, in February 2020, researchers from Arvalis-Institut du Végétal, France, reported development of novel approach to use a Fourier-based patterning strategy for low-cost hyperspectral single pixel imaging. Moreover, R&D of novel 3D imaging technologies is also expected to aid in growth of the market. For instance, in June 2019, a community of researchers at the Southampton demonstrated novel 3D imaging technologies at The Southampton Bioimaging Symposium.

Increasing adoption of light-based technologies in the agriculture sector is expected to offer lucrative growth opportunities for players in the global biophotonics market. Moreover, increasing demand for GMO crops is also expected to aid in growth to the market.

Increasing geriatric population is expected to offer conducive environment for growth of the global biophotonics market. For instance, according to the U.S. Census Bureau, the U.S. geriatric population is expected to reach 77 million by 2034. Moreover, entry of new players in the healthcare sector and increasing application of biophotonics in nanotubes, LEDs, quantum dots, silicon-on-insulator, surface plasmons, micro- and nanophotonics, heterostructured lasers, and optical fibers & waveguides is also expected to aid in growth of the market.

Browse Press Release:

However, lack of government initiatives to boost adoption of biophotonics is expected to limit growth of the global biophotonics market. Moreover, the emerging field is still in its nascent stage and market players rely on funding for R&D in the field. Small and medium scale companies involved in biophotonics heavily rely on government funding for R&D.

Key Takeaways

  • R&D of low-cost sensors and vectors for plant phenotyping is expected to propel growth of the global biophotonics market
  • Major players in the market are focused on adopting M&A strategies to expand their product portfolio. For instance, in March 2020, Hamamatsu Photonics acquired a 55% stock share in HAMAMATSU PHOTONICS KOREA Co., Ltd. in the Republic of Korea.
  • Major players operating in the global biophotonics market include Becton, Dickinson & Co., Affymetrix Inc., Carl Zeiss, Olympus America, Andor Technology, and Hamamatsu Photonics

Apply Promo Code “CMIFIRST1000” And Get Instant Discount Of USD 1000
Buy Now this Premium Report to Grow your Business @

About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website –


Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

This content has been distributed via CDN Newswire press release distribution service. For press release enquires please mail us at

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 24-Jul-2020